Hemab Therapeutics Holdings Inc

The consensus rating is the average recommendation across all covering analysts, ranging from Strong Sell to Strong Buy. It reflects the overall sentiment of the analyst community, not a guarantee of future performance.

The average price target is the mean of the individual 1-year price targets set by covering analysts. It's shown alongside the high and low targets to illustrate the range of analyst expectations.

Implied upside is the percentage difference between the current share price and the average analyst price target. A positive value suggests analysts expect the price to rise; a negative value suggests they expect it to fall.

Ratings and price targets are refreshed as analysts publish new research. Consensus figures compare the last 3 months against the prior period to highlight shifts in sentiment.